Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Avantor, Inc. (AVTR)
|
Add to portfolio |
|
|
|
| Price: |
$39.17
| | Metrics |
| OS: |
675.9
|
M
| |
|
|
| Market cap: |
$26.5
|
B
| |
|
|
|
Net debt:
|
$5.65
|
B
| |
|
|
|
EV:
|
$32.1
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
| Date Filed | Type | Description |
| 10/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/04/2023 |
4
| Gourdier Benoit (EVP, Biopharma Production) has filed a Form 4 on Avantor, Inc. |
| 10/04/2023 |
3
| Gourdier Benoit (EVP, Biopharma Production) has filed a Form 3 on Avantor, Inc. |
| 08/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/24/2023 |
3
| Hankamer Brittany (EVP, Chief HR Officer) has filed a Form 3 on Avantor, Inc. |
| 08/09/2023 |
4
| Jones R. Brent (EVP, CFO) has filed a Form 4 on Avantor, Inc. |
| 08/09/2023 |
3
| Jones R. Brent (EVP, CFO) has filed a Form 3 on Avantor, Inc. |
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 7,512.4 | 7,386.1 | 6,393.6 | 6,040.3 | 5,864.3 | 1,247.4 | 691.3 | 636.9 |
| Revenue growth | 1.7% | 15.5% | 5.8% | 3.0% | 370.1% | 80.4% | 8.5% | |
| Cost of goods sold | 4,909.6 | 4,883.4 | 4,313.1 | 4,119.6 | 4,044.5 | 814.6 | 371.6 | 374.7 |
| Gross profit | 2,602.8 | 2,502.7 | 2,080.5 | 1,920.7 | 1,819.8 | 432.8 | 319.7 | 262.2 |
| Gross margin | 34.6% | 33.9% | 32.5% | 31.8% | 31.0% | 34.7% | 46.2% | 41.2% |
| Selling, general and administrative | 1,472.6 | 1,530.5 | 1,373.7 | 1,368.9 | 1,405.3 | 449.7 | 281.5 | 200.6 |
| EBITA | 1,448.5 | 1,263.0 | 1,014.3 | 864.1 | 734.8 | -145.2 | 9.9 | 60.6 |
| EBITA margin | 19.3% | 17.1% | 15.9% | 14.3% | 12.5% | -11.6% | 1.4% | 9.5% |
| Amortization of intangibles | 318.3 | 290.8 | 307.5 | 312.3 | 321.3 | 65.2 | | |
| EBIT | 1,130.2 | 972.2 | 706.8 | 551.8 | 413.5 | -210.4 | 9.9 | 60.6 |
| EBIT margin | 15.0% | 13.2% | 11.1% | 9.1% | 7.1% | -16.9% | 1.4% | 9.5% |
| Pre-tax income | 851.1 | 753.0 | 62.3 | 40.6 | -113.8 | -460.2 | -70.6 | 29.8 |
| Income taxes | 164.6 | 180.4 | -54.3 | 2.8 | -26.9 | -314.9 | 10.1 | 17.1 |
| Tax rate | 19.3% | 24.0% | | 6.9% | 23.6% | 68.4% | | 57.4% |
| Net income | 662.3 | 508.0 | 52.0 | -335.1 | -356.4 | -414.9 | -42.4 | 21.6 |
| Net margin | 8.8% | 6.9% | 0.8% | -5.5% | -6.1% | -33.3% | -6.1% | 3.4% |
| |
| Diluted EPS | $0.97 | $0.85 | $0.09 | ($0.84) | ($2.69) | ($2.75) | ($277.85) | $0.64 |
| Shares outstanding (diluted) | 679.4 | 599.6 | 583.4 | 401.2 | 132.7 | 151.1 | 0.2 | 33.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|